Nuoncology Labs Inc
OTC:NLAB
Nuoncology Labs Inc
Cash from Financing Activities
Nuoncology Labs Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nuoncology Labs Inc
OTC:NLAB
|
Cash from Financing Activities
$29.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Montrose Environmental Group Inc
NYSE:MEG
|
Cash from Financing Activities
-$20.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DermTech Inc
NASDAQ:DMTK
|
Cash from Financing Activities
$6.1m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
189%
|
CAGR 10-Years
N/A
|
|
Sotera Health Co
NASDAQ:SHC
|
Cash from Financing Activities
$266m
|
CAGR 3-Years
54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sera Prognostics Inc
NASDAQ:SERA
|
Cash from Financing Activities
$752k
|
CAGR 3-Years
-57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Spectaire Holdings Inc
NASDAQ:SPEC
|
Cash from Financing Activities
-$212.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nuoncology Labs Inc's Cash from Financing Activities?
Cash from Financing Activities
29.2k
USD
Based on the financial report for Dec 31, 2021, Nuoncology Labs Inc's Cash from Financing Activities amounts to 29.2k USD.